What is Ribocure Pharmaceuticals AB's contact information?

Ribocure Pharmaceuticals AB's contact information: contact@ribocure.com, john.taylor@ribocure.com, dpo@ribocure.com, +46 31 720 78 00, 559366-4377, +46317207800.

How many employees does Ribocure Pharmaceuticals AB have?

Ribocure Pharmaceuticals AB has 38 employees.

What industry does Ribocure Pharmaceuticals AB belong to?

Ribocure Pharmaceuticals AB is in the industry of: Pharmaceuticals, Biotechnology, Healthcare.

What are Ribocure Pharmaceuticals AB's official social media profiles?

Ribocure Pharmaceuticals AB Linkedin Page

What tech stack does Ribocure Pharmaceuticals AB use?

Some of the popular technologies that Ribocure Pharmaceuticals AB uses are: Google Analytics, WordPress, WordPress.

What are Ribocure Pharmaceuticals AB's office addresses?

Ribocure Pharmaceuticals AB has 2 known office addresses: Vetenskapens Gränd 11, Floor 5, SE-431 53 Mölndal, Sweden Medicinaregatan 8a Gothenburg, Vastra Gotaland County 413 90, SE.

What is Ribocure Pharmaceuticals AB's estimated annual revenue?

Ribocure Pharmaceuticals AB's revenue is $1,000,000

What is Ribocure Pharmaceuticals AB's open headcount?

Ribocure Pharmaceuticals AB has 6 job postings.

What is the number of ad campaigns for Ribocure Pharmaceuticals AB?

Ribocure Pharmaceuticals AB has no advertisements yet.

What is the number of recent news articles about Ribocure Pharmaceuticals AB?

Ribocure Pharmaceuticals AB has 7 news articles.

Ribocure Pharmaceuticals AB - Pubrio Company Profile & Intent

Ribocure Pharmaceuticals AB

Sweden · Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

We are a clinical stage biotech company focusing oligonucleotide therapeutics. With presence in Gothenburg, Sweden, and with our own clinical trial facility, and clinical and R&D expertise.

Company Insights

prnasia.com · partners_with · 4 weeks ago

Open news

Ribocure and Madrigal partner for MASH siRNA therapies

Ribocure and Madrigal partner to develop six innovative siRNA therapies for MASH, with a $60 million upfront payment and potential $4.4 billion in milestone payments.

Madrigal Pharmaceuticals

Ribocure Pharmaceuticals Ab

Suzhou Ribo Life Science Co. Ltd.

prnasia.com · partners_with · 4 weeks ago

Open news

Ribocure and Madrigal partner for MASH siRNA therapies

Ribocure and Madrigal partner to develop six innovative siRNA therapies for MASH, with a $60 million upfront payment and potential $4.4 billion in milestones.

Madrigal Pharmaceuticals

Ribocure Pharmaceuticals Ab

Suzhou Ribo Life Science Co. Ltd.

prnasia.com · partners_with · 4 weeks ago

Open news

Ribo and Madrigal partner on MASH siRNA therapies

Ribo and Madrigal sign exclusive licensing agreement for six pre-clinical siRNA programs to treat MASH, with potential payments of $4.4B.

Madrigal Pharmaceuticals

Ribocure Pharmaceuticals Ab

Suzhou Ribo Life Science Co. Ltd.

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 7 of 7

Frequently Asked Questions Regarding Ribocure Pharmaceuticals AB

Company Overview

2022

Founded

Biotechnology

Industry

Sweden

Location

3,141,042

Ranking

38 employees

Size

Similar Companies

Get full access to view complete information